Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9921392 | European Journal of Pharmacology | 2005 | 13 Pages |
Abstract
Mechanism, onset and duration of tolerance development to clomethiazole-induced hypothermia were investigated in rats using telemetry. The hypothermic effect of clomethiazole was completely abolished for 10 days after an s.c. injection of 300 μmol/kg and the effect returned to â¼50% in 32 days. The γ-aminobutyric acidA (GABAA) receptor agonist muscimol induced hypothermia at 88 μmol/kg without any (cross-) tolerance. GABAA receptor antagonists, bicuculline (5.4 μmol/kg) and picrotoxin (3.3 μmol/kg), did not inhibit clomethiazole-induced hypothermia nor the tolerance. The noncompetitive N-methyl-d-aspartate (NMDA) receptor antagonist, dizocilpine, counteracted clomethiazole-induced hypothermia at 3 μmol/kg but not the tolerance. Tolerance to the 5-hydroxytryptamine1A (5-HT1A) receptor agonist R-(+)-8-hydroxy-2-(di-n-propylamino)tetralin (R-8-OH-DPAT)-induced hypothermia was blocked by dizocilpine and clomethiazole but not vice versa. No pharmacokinetic interaction was observed. In conclusion, long-lasting tolerance to clomethiazole-induced hypothermia does not involve GABAA or 5-HT1A receptor functions. Glutamate via NMDA receptors may be involved in the hypothermic response but not in the tolerance.
Related Topics
Life Sciences
Neuroscience
Cellular and Molecular Neuroscience
Authors
Sandra A.G. Visser, Susanna Pozarek, Sofia Martinsson, Tomas Forsberg, Svante B. Ross, Johan Gabrielsson,